Promiscuous plasmids? Scaling infection control implications of horizontal spread of carbapenemase genes between species Siddharth Mookerjee, Frances Davies,

Slides:



Advertisements
Similar presentations
Trends in fungal disease in the UK Theresa Lamagni Healthcare-Associated Infection & Antimicrobial Resistance Department HPA Centre for Infections.
Advertisements

Game plan Lecture Antibiotics Antibiotic resistance Gene transfer Transformation Transduction Conjugation Lab Lab Exam Pre-lab Transformation.
1. 2 Global Travel – who goes? 3 Global Links of NDM to the UK Kumarasamy et al., Lancet Infect Dis :
Global spread of antibiotic resistance: the example of New Delhi metallo-b-lactamase (NDM)-mediated carbapenem resistance Songzhen
The Rise of Carbapenem Resistant Organisms
Infection Control in Long Term Care Settings Moderator: Carol Goldman, RN, BScN, CIC Infection Control Consultant IFIC Board member, CHICA-Canada Expert.
Support and Assessment for Fall Emergencies (SAFE) Trial An evaluation of the costs and benefits of computerised on-scene decision support for emergency.
Costs.
FALL 2010 Course: Biology 225 Instructor: Dr. Janie Sigmon Hot Topics in Microbiology.
The epidemiology of HAI Scotland Dr Jacqui Reilly Consultant Epidemiologist Head of HAI and IC Group.
Vesicle-Mediated Transfer of Antibiotic Resistance Between Klebsiella pneumoniae and Serratia marcescens Ondraya Espenshade Department of Biological Sciences,
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
What’s happening now ? Epidemiology of (carbapenem) resistance Neil Woodford HPA – AMRHAI - Colindale.
The role of the English Surveillance Programme on Antimicrobial Use & Resistance in improving stewardship Susan Hopkins Consultant Infectious Diseases.
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.
European Centre for Disease Prevention and Control
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
Development of a Real-Time PCR (RT-PCR) Assay for Carbapenemase Producing Bacteria including Enterobacteriaceae B. Mather, P. L. White, M. Wootton, R.
The role of PHE’s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit © Crown.
Part II High Priority Resistant Organisms. Healthcare Associated Infections NHSN Staphylococcus aureus (16%) 2.Enterococcus spp (14%) 3.Escherichia.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
CRE/CPE/CRO: Demystifying the microbiology and opportunities for whole genome sequencing Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust 
CPE, CRE, CPO and CRABs! Jon Otter, PhD FRCPath Imperial College Hospitals NHS Trust Blog:
Improving Infection Prevention & Control Practices
Evaluating the clinical and cost effectiveness
Alison Holmes, Jonathan Otter
Cascade of care for persons newly diagnosed
Professor Alan Johnson Department of HCAI & AMR
Evaluation of a pilot support package for hospital
2. Methods and Measurements
Screening for CPE: sensitivity of serial admission screens
Who’s carrying CPE? Universal admission screening in London
Managing repeated screening for known CPE carriers: once positive always positive? Siddharth Mookerjee, Eleonora Dyakova, Frances Davies, Kathleen Bamford,
GNBSI Can we really halve GNBSIs? Jon Otter, PhD FRCPath
Bacteraemia in Buckinghamshire Healthcare NHS Trust
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Counting the cost of controlling an outbreak of CPE: an economic evaluation Jonathan A. Otter,1,2 Philip Burgess,3 Frances Davies,2 Siddharth Mookerjee,2.
Nine decades of antibiotics: how many years of antibiotic resistance?
Using the Toolkit to build a CPE policy
Main modes of transmission CPE
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
Counting the cost and value of hospital cleaning and disinfection
Carbapenem-resistant Gram-negative bacteria
Changes to 10A NCAC 41A May 5, 2018.
From hospital microbiome to new answers for environmental cleaning
Cost utility of alternative Carbapenemase
Table 1: Resistance profile
Fast and expensive or cheap and slow
Overseas travel and antibiotic use are more important than community demographics or measures of social and material deprivation in predicting ESBL colonization.
Antibiotic Resistance: Strategic Solutions
ECDC point prevalence survey (PPS)
Measuring and improving compliance with risk-factor based CPE admission screening Siddharth Mookerjee,1 Kate Martin, 1 Itziar Atucha-Zambrano, 1 Rebecca.
AMR: a clinical perspective
CPE: coming to a hospital near you!
“Can I swab your rectum please
Detecting and managing CPE outbreaks: seek and you shall find
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Hospital cleaning and disinfection: we can do better!
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, USA Emergence of VIM-2 Metallo--lactamase.
Antibiotic Resistance
The management of CPE outbreaks panel
Implementing innovation when financial times are hard
Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective  J.A. Otter, P. Burgess,
TRAINING PRESENTATION
Jennifer Henderson1,2, Holly Ciesielczuk1, Shona Nelson2 & Mark Wilks1
Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
An introduction to infectious diseases epidemiology
Belinda Ostrowsky, MD, MPH Field Medical Officer, NY
Presentation transcript:

Promiscuous plasmids? Scaling infection control implications of horizontal spread of carbapenemase genes between species Siddharth Mookerjee, Frances Davies, Eleonora Dyakova, Tracey Galletly, Alison Holmes, Jonathan Otter Imperial College Healthcare NHS Trust & Imperial College London  jon.otter@nhs.net @jonotter Introduction Carbapenemase-producing Enterobacteriaceae (CPE) are of urgent public health concern, with a steady increase in incidence year on year in the UK.1 It is currently unclear how much importation from abroad vs. transmission of CPE within UK healthcare and community settings contributes to the UK CPE picture.2 Local CPE cluster investigation led us to analyse CPE carriage over time in relation to mechanism of resistance and speciality, with the aim of potentially identifying inter-species horizontal carbapenemase gene transfer. 2. Methods All CPE isolates over a four year period, April 2013 to March 2017, were analysed. We compared clusters of same-species-same- mechanism combinations with clusters of same- mechanism-any-species combinations. We focused our analysis on four specialities that bore the highest burden of CPE cases: Intensive Care Units (ICU), Medicine, Renal and Vascular, analysing CPE cases over time. A cluster was defined as more than or equal to three cases over a period of a month in a single speciality. 4. Discussion IPC efforts have focussed on same-mechanism-same-species CPE clusters locally. However, our findings study suggest unidentified plasmid-mediated transfer of carbapenemases resulting in multiple undetected same-mechanism-any-species clusters. The renal wards are the most common areas affected by both same-species-same-mechanism and same-mechanism-any-species clusters. Our results indicate that a comprehensive approach to preventing the transmission of CPE should consider the possibility of horizontal spread of carbapenemases between bacterial species. We have widened our approach to preventing the transmission of CPE, by considering same-mechanism-any-species analysis in our cluster investigations. 3. Results 23 same-species-same-mechanism clusters were found in the period April 2013 to March 2017 with 52% (12/23) Klebsiella pneumoniae NDM and 30% (7/23) K. pneumoniae OXA-48 being the most common combinations The speciality of Renal bore the highest burden, with 43% of clusters (10/23), of which 40% (4/10) were K. pneumoniae NDM and 60% (6/10) K. pneumoniae OXA- 48 41 same-mechanism-any-species clusters were identified over the same period, with 56% (23/41) OXA- 48 and 37% (15/41) NDM related clusters, with the speciality of Renal again bearing the highest burden, with 49% (20/41) of clusters, 25% (5/20) of which were NDM, and 75% (15/20) of which were OXA-48. References Public Health England. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report. 2016 Findlay J., Hopkins KL., Alvarez-Buylla A., et al. Characterization of carbapenemase-producing Enterobacteriaceae in the West Midlands region of England: 2007-14. J Antimicrobial Chemother. 2017; 72(4): 1054-1062 Disclosures: JO is a consultant to Gama.